Complete remission after patisiran treatment in a patient with nephrotic syndrome secondary to hereditary transthyretin amyloidosis (ATTR)

被引：0
|
作者：
Vila, Axel [1 ]
Moktefi, Anissa [2 ,3 ]
Damy, Thibaud [4 ,5 ]
Plante-Bordeneuve, Violaine [6 ]
Remy, Philippe [1 ]
Colombat, Magali [7 ]
Audard, Vincent [1 ,2 ]
Sakhi, Hamza [1 ,2 ]
机构：
[1] Hop Univ Henri Mondor, Assistance Publ Hop Paris APHP, Ctr Reference Malad Rare Syndrome Nephrot Idiopath, Serv Nephrol & Transplantat, Creteil, France
[2] Univ Paris Est Creteil, Inst Mondor Rech Biomed IMRB, Inst Natl Sante & Rech Med, INSERM U955, Creteil, France
[3] Hop Univ Henri Mondor, Serv Anatomopathol, Creteil, France
[4] Univ Paris Est Creteil, Equipe CEpiA Clin Epidemiol & Aging, INSERM U955, IMRB, Creteil, France
[5] Hop Univ Henri Mondor, AP HP, Serv Cardiol, GRC Amyloid Res Inst,Ctr Reference Natl Amyloses C, Creteil, France
[6] Hop Univ Henri Mondor, AP HP, GRC Amyloid Res Inst, Serv Neurol, Creteil, France
[7] Ctr Hosp Univ Toulouse, Serv Anatomopathol, Toulouse, France
来源：
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS | 2025年
关键词：
Hereditary Transthyretin Amyloidosis; Nephrotic Syndrome; Patisiran; Tafamidis;
D O I：
10.1080/13506129.2025.2472819
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Patisiran for the treatment of hereditary transthyretin-mediated amyloidosis
    Yang, Junyi
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2019, 12 (02) : 95 - 99
  • [2] Complete Remission of Nephrotic Syndrome Secondary to Amyloid A Amyloidosis in Patient with Inactive Crohn's Disease after Treatment by Infliximab
    Hassani, Kawtar
    Hamzi, Mohamed Amine
    El Kabbaj, Driss
    SAUDI JOURNAL OF KIDNEY DISEASES AND TRANSPLANTATION, 2018, 29 (02) : 456 - 461
  • [3] Current approaches for treatment of hereditary transthyretin amyloidosis (ATTR)
    Zibert, Andree
    Huesing-Kabar, Anna
    Schmidt, Hartmut
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2019, 144 (20) : 1438 - 1443
  • [4] Treatment with patisiran of a patient with hereditary transthyretin-mediated amyloidosis with stage 3 polyneuropathy
    Mueschen, Lars H.
    Koerner, Gudrun
    Gingele, Stefan
    Haenselmann, Anja
    Bavendiek, Udo
    Skripuletz, Thomas
    MUSCLE & NERVE, 2021, 64 (03) : E11 - E13
  • [5] A Review of Patisiran (ONPATTRO®) for the Treatment of Polyneuropathy in People with Hereditary Transthyretin Amyloidosis
    Ivan Urits
    Daniel Swanson
    Michael C. Swett
    Anjana Patel
    Kevin Berardino
    Ariunzaya Amgalan
    Amnon A. Berger
    Hisham Kassem
    Alan D. Kaye
    Omar Viswanath
    Neurology and Therapy, 2020, 9 : 301 - 315
  • [6] A Review of Patisiran (ONPATTRO®) for the Treatment of Polyneuropathy in People with Hereditary Transthyretin Amyloidosis
    Urits, Ivan
    Swanson, Daniel
    Swett, Michael C.
    Patel, Anjana
    Berardino, Kevin
    Amgalan, Ariunzaya
    Berger, Amnon A.
    Kassem, Hisham
    Kaye, Alan
    Viswanath, Omar
    NEUROLOGY AND THERAPY, 2020, 9 (02) : 301 - 315
  • [7] Patisiran, an RNAi therapeutic for the treatment of hereditary transthyretin-mediated amyloidosis
    Kristen, Arnt, V
    Ajroud-Driss, Senda
    Conceicao, Isabel
    Gorevic, Peter
    Kyriakides, Theodoros
    Obici, Laura
    NEURODEGENERATIVE DISEASE MANAGEMENT, 2019, 9 (01) : 5 - 24
  • [8] Patisiran treatment in patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy after liver transplantation
    Schmidt, Hartmut H.
    Wixner, Jonas
    Plante-Bordeneuve, Violaine
    Munoz-Beamud, Francisco
    Llado, Laura
    Gillmore, Julian D.
    Mazzeo, Anna
    Li, Xingyu
    Arum, Seth
    Jay, Patrick Y.
    Adams, David
    AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 (06) : 1646 - 1657
  • [9] An evaluation of patisiran: a viable treatment option for transthyretin-related hereditary amyloidosis
    Milani, Paolo
    Mussinelli, Roberta
    Perlini, Stefano
    Palladini, Giovanni
    Obici, Laura
    EXPERT OPINION ON PHARMACOTHERAPY, 2019, 20 (18) : 2223 - 2228
  • [10] Correction to: A Review of Patisiran (ONPATTRO®) for the Treatment of Polyneuropathy in People with Hereditary Transthyretin Amyloidosis
    Ivan Urits
    Daniel Swanson
    Michael C. Swett
    Anjana Patel
    Kevin Berardino
    Ariunzaya Amgalan
    Amnon A. Berger
    Hisham Kassem
    Alan D. Kaye
    Omar Viswanath
    Neurology and Therapy, 2021, 10 : 407 - 407
12345